Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea

Area of Science:

• Immunology
• Gastroenterology
• Microbiology

Background:

• Bacterium-induced diarrhea causes millions of deaths annually, necessitating a deeper understanding of its mechanisms.
• Staphylococcus aureus is linked to diarrhea, with its cell wall component, peptidoglycan (PGN), exhibiting potent immune activity.
• The role of PGN in S. aureus-induced diarrhea requires further investigation.

Purpose of the Study:

• To investigate the role of oral peptidoglycan (PGN) in inducing diarrhea.
• To elucidate the cellular and molecular mechanisms underlying PGN-induced diarrhea.
• To explore potential therapeutic strategies for PGN-induced diarrhea.

Main Methods:

• Oral administration of PGN to mice to assess diarrhea induction in a dose-dependent manner.
• Investigation of PGN absorption by intestinal epithelial cells.
• Analysis of mast cell activation and Toll-like receptor (TLR)2 expression in intestinal tissues and cell lines.
• Blocking studies using antibodies or RNA interference targeting TLR2 and NOD1.
• Assessment of mast cell mediators like histamine and serotonin.

Main Results:

• Oral PGN induced diarrhea in mice dose-dependently.
• Intestinal epithelial cells absorbed PGN via an intracellular pathway.
• PGN activated intestinal mast cells, with TLR2 detected on these cells.
• Blocking TLR2 or NOD1 inhibited PGN-induced mast cell activation.
• Histamine and serotonin showed synergistic effects in PGN-induced diarrhea.

Conclusions:

• Oral PGN can induce diarrhea in mice.
• TLR2 and NOD1 signaling pathways mediate PGN-induced mast cell activation, a key factor in diarrhea.
• Blocking TLR2 or NOD1, or using mast cell stabilizers, can effectively inhibit PGN-induced diarrhea, indicating therapeutic potential.